CompoAtlas

PHYTOSPAGYRIE N°22 NERVOSITE-ADDICTION

Food supplement declared in France, declaration No 2020-1-581, decision dated 17 January 2020

PHYTOSPAGYRIE N°22 NERVOSITE-ADDICTION (HERBIER DU VELAY) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Betula pendula 660 mg per day, Tilia platyphyllos 660 mg per day, Crataegus laevigata 150 mg per day, Alnus glutinosa 20 mg per day, Abies alba 5 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
HERBIER DU VELAY
Food business operator placing the product on the market
SAS VECTEUR ENERGY
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
10
Directions for use
Prendre 5 ml (1 cuillère à café) matin et soir, à diluer dans 5 à 10 volumes d'eau. Agiter avant uti
Not recommended (according to the manufacturer)
Allergy to salicylate derivatives, Taking anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Antioxidant, Mood, Immunity, Sleep, Nervous system

Declaration 216410, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Betula pendula RothFeuilleMacérât hydroglycériné660 mg
Tilia platyphyllos Scop.FleurMacérât hydroglycériné660 mg
Crataegus laevigata (Poir.) DC.Sommités fleuriesMacérât hydroglycériné150 mg
Alnus glutinosa (L.) Gaertn.Feuille (bourgeon)Macérât hydroglycériné20 mg
Abies alba Mill.AiguilleHydrolât (eau florale)5 mg

Additives

E422

Other ingredients

Vitis vinifera L.

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Label warnings

Le bouleau est déconseillé aux personnes souffrant d'allergie aux dérivés salicylés et sous traitement anti-coagulant.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Betula pendula Roth
    Read the warning, when it applies and the studies cited

    Birch

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney or cardiovascular disorders (Brinker 2010; Bradley 2006; ESCOP 2003; Blumenthal et al. 1998).

    Sources cited by Health Canada (4)
    • Blumenthal M, Busse W, Goldberg A, Gruenwald J, Hall T, Riggins C, Rister R, editors. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin (TX): American Botanical Council; 1998.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (UK): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (UK): European Scientific Cooperative on Phytotherapy and Thieme; 2003.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Health Canada monograph dated 28 August 2024

  • Tilia platyphyllos Scop.
    Read the warning, when it applies and the studies cited

    Linden - TILIA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Mills and Bone 2005; De Smet 1993).

    Sources cited by Health Canada (2)
    • De Smet PAGM, Keller K, Hansel R, Chandler RF, editors. Adverse Effects of Herbal Drugs, Volume 2. Berlin (DE): Springer-Verlag; 1993.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Crataegus laevigata (Poir.) DC.
    Read the warning, when it applies and the studies cited

    Hawthorn

    Route of administration: Oral (ESCOP 2009; Bradley 2006; Mills and Bone 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking cardiac glycosides (e.g., digoxin) or blood pressure or heart medications (Brinker 2010; Bradley 2006).

    Sources cited by Health Canada (2)
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have chest pain, irregular heartbeat, or shortness of breath.

    Health Canada monograph dated 31 July 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : HERBIER DU VELAY

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PHYTOSPAGYRIE N°22 NERVOSITE-ADDICTION (HERBIER DU VELAY): composition and regulation”, https://compoatlas.com/en/supplements/products/216410-phytospagyrie-n-22-nervosite-addiction, updated 15 November 2026.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line